October 2, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood accurately identified patients with a high risk of cervical cancer recurrence after t

October 1, 2023 — The presence of a clinical navigator to act as a liaison between people with prostate cancer and the healthcare system greatly increases the likelihood that patients, especially Black patients, will receive advanced testing that can help predict

September 29, 2023 — Hologic, Inc., a global leader in women’s health, announced a series of activities promoting the importance of breast cancer screenings throughout Breast Cancer Awareness Month, including a global partnership with Know Your Lemons, a nonprofit organization committed to improving early detection of breast cancer worldwide through creative and

September 29, 2023 — Qure.ai, a leading global innovator in radiology AI solutions, has announced FDA clearance for measuring the cardiothoracic ratio (CTR) utilizing its artificial intelligence-enabled chest X-ray solution, qXR-CTR. This remarkable achievement marks another significant milestone for the organization, solidifying its position as a trailblazer in AI-driven medical imaging innovation.  

September 29, 2023 — RaySearch will be showcasing the latest software innovations at ASTRO in San Diego, California, October 1-4.

September 29, 2023 — Varian, a Siemens Healthineers company, is showcasing technologies that reflect its continued commitment to embracing innovation and enhancing outcomes for cancer patients at this year's 2023 American Society for Radiation Oncology (ASTRO) annual meeting, taking place from October 1-4 in San Diego, California. 

October 1, 2023 — The 2023 Abstract Award winners have been announced by the American Society for Radiation Oncology (ASTRO) during its 65th Annual Meeting, ASTRO 2023,  being held Oct. 1-4 in San Diego, CA. Winners are chosen based on their peer reviewed scores and final abstract review by the Annual Meeting Steering Committee.

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical cancer are at lower risk for long-term side effects, according to a new study from researchers in Austria.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now